Welcome to AnDiaTec®
AnDiaTec GmbH & Co.KG was founded in the summer of 2003. The company develops and produces innovative assays for challenging diagnostic parameters. Due to the sophisticated technology provided, the assays are user-friendly and simple, but at the same time guarantee reliable and sensitive diagnostic results. Thus, AnDiaTec was priced with the international Animal Pharm Award in 2007.
The product range includes in vitro diagnostics for human and veterinary applications, plus assays for food industries and environmental purposes. The portfolio encloses real time PCR and conventional PCR, as well as antibody and antigen detection by immunological methods. The tests are produced according to DIN EN ISO IEC 13485 and IVD 98/79/EG (CE label) for human diagnostics or German Animal Disease Law §17 TierSG for veterinary diagnostics. Additionally, the lab facility is accredited according to directive 9CFR by the USDA for production and export of the veterinary diagnostic tests to the United States.
The human diagnostic tests are sold worldwide in more than 40 countries thanks to a wide net of various distributors. The veterinary products are distributed worldwide by Enfer Diagnostics Ltd. In addition, Enfer and AnDiaTec are operating a veterinary diagnostic lab in Manhattan, KS.
The lab in Kornwestheim, Germany, is accredited according to DIN EN ISO IEC 17025 and 15189. Lab services regarding human and veterinary diagnostics, as well as food and environmental analysis are offered.
AnDiaTec also participates in basic research. Thus, among other projects, the company serves as a consultant for the WHO in an Enterovirus diagnostics project in India and assists the NMI in Tübingen, Germany, in the development of new innovative technologies. Further co-operations with universities in Germany and in other countries allow a permanent exchange of experience and knowledge.
The AnDiaTec GmbH & Co. KG is always amenable to new co-operation partners, for the development of novel and innovative assays and for the distribution of the products into emerging markets.
|